A Food and Drug Administration advisory panel has unanimously recommended granting emergency use authorization for a third Moderna shot, though only some people
A Food and Drug Administration advisory panel has unanimously recommended granting emergency use authorization for a third Moderna shot, though only some people would be eligible for the booster shot. The recommendation follows Moderna’s second-quarter financial details shared in August, which included information on the COVID-19 vaccine’s efficacy six months after the second dose, as well as the booster for its booster shots to help protect against SARS-CoV-2 variants. The recommendation comes from advisers with the FDA, paving the way for an Emergency Use Authorization and a second COVID-19 booster shot option in the US.
